Cellgen Diagnostics

🗓 Founded 2012👥 1 employees💰 Last funded Apr 2020
Medical Equipment Manufacturing🌐 cellgendx.com
Website LinkedIn
Cellgen is developing a bio-fluid based molecular diagnostic that will serve as a therapeutic guidance platform for cancer patients. The platform incorporates machine learning to deliver intelligent, quantitative and actionable results to oncologists in under 5 hours. Designed to detect all DNA and RNAs, Cellgen’s platform features a proprietary on-chip enrichment and detection workflow perfectly suited to be installed as the premier Companion Diagnostic testing system within leading oncology clinics. Running on Cellgens proprietary platform, each disposable assay will yield inclusion / exclusion data, while also leveraging proprietary machine learning algorithms to intelligently monitor and predict therapeutic response. This information will help inform patients, physicians, and others on how best to simplify and optimize life-saving clinical protocols.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Cellgen Diagnostics?
Cellgen Diagnostics has 1 investors on record on gritt.io and 1 late-stage investors.
When did Cellgen Diagnostics last raise funding?
The most recent investment in Cellgen Diagnostics recorded on gritt.io was in April 2020.
When was Cellgen Diagnostics founded?
Cellgen Diagnostics was founded in 2012.
What industry is Cellgen Diagnostics in?
Cellgen Diagnostics operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.